Cargando…

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort

Patients with chronic obstructive pulmonary disease (COPD) who are defined as frequent exacerbators suffer with 2 or more exacerbations every year. The molecular mechanisms responsible for this phenotype are poorly understood. We investigated gene expression profile patterns associated with frequent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Dave, Fox, Steven M., Tal-Singer, Ruth, Bates, Stewart, Riley, John H., Celli, Bartolome
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179270/ https://www.ncbi.nlm.nih.gov/pubmed/25265030 http://dx.doi.org/10.1371/journal.pone.0107381

Ejemplares similares

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

Characterisation of COPD heterogeneity in the ECLIPSE cohort
por: Agusti, Alvar, et al.
Publicado: (2010)

COPD association and repeatability of blood biomarkers in the ECLIPSE cohort
por: Dickens, Jennifer A, et al.
Publicado: (2011)

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
por: Celli, Bartolome, et al.
Publicado: (2021)

Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial
por: Betts, Joanna C, et al.
Publicado: (2015)

Exacerbation frequency and course of COPD
por: Halpin, David MG, et al.
Publicado: (2012)

Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021)

Genetics of Sputum Gene Expression in Chronic Obstructive Pulmonary Disease
por: Qiu, Weiliang, et al.
Publicado: (2011)

Specific elastin degradation products are associated with poor outcome in the ECLIPSE COPD cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
por: Charriot, Jeremy, et al.
Publicado: (2023)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD – results from the ECLIPSE study
por: Sand, Jannie M. B., et al.
Publicado: (2016)

Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
por: Su, Jin, et al.
Publicado: (2015)

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD
por: Boixeda, Ramon, et al.
Publicado: (2015)

Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation
por: DeVries, Rebecca, et al.
Publicado: (2016)

Combining biomarkers of clot resolution and alveolar basement membrane destruction predicts mortality in the ECLIPSE COPD cohort
por: Sand, Jannie M.B., et al.
Publicado: (2020)

Blood neutrophil counts are associated with exacerbation frequency and mortality in COPD
por: Lonergan, Mike, et al.
Publicado: (2020)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

The Most Common Detected Bacteria in Sputum of Patients with the Acute Exacerbation of COPD
por: Cukic, Vesna
Publicado: (2013)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices
por: Su, Linfan, et al.
Publicado: (2022)

Sputum Cytokine Profiling in COPD: Comparison Between Stable Disease and Exacerbation
por: Barta, Imre, et al.
Publicado: (2022)

Breathing–swallowing discoordination is associated with frequent exacerbations of COPD
por: Nagami, Shinsuke, et al.
Publicado: (2017)

Antiviral immunity is impaired in COPD patients with frequent exacerbations
por: Singanayagam, Aran, et al.
Publicado: (2019)

Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort
por: Rønnow, Sarah Rank, et al.
Publicado: (2019)

Endotrophin, an extracellular hormone, in combination with neoepitope markers of von Willebrand factor improves prediction of mortality in the ECLIPSE COPD cohort
por: Rønnow, Sarah R., et al.
Publicado: (2020)

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Su, Linfan, et al.
Publicado: (2022)

Blood miRNAs Are Linked to Frequent Asthma Exacerbations in Childhood Asthma and Adult COPD
por: Tiwari, Anshul, et al.
Publicado: (2022)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
por: Lin, Chieh-Mo, et al.
Publicado: (2020)

The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population
por: Hazra, Druti, et al.
Publicado: (2023)

The sputum microbiome is distinct between COPD and health, independent of smoking history
por: Haldar, Koirobi, et al.
Publicado: (2020)

Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD
por: Gao, Jie, et al.
Publicado: (2017)

Predicting frequent COPD exacerbations using primary care data
por: Kerkhof, Marjan, et al.
Publicado: (2015)

Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients
por: Wu, Yao-Kuang, et al.
Publicado: (2021)

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT(®) Trial
por: Halpin, David M. G., et al.
Publicado: (2011)

Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy
por: Martin, Mickaël, et al.
Publicado: (2017)

Frequent sputum production is associated with disturbed night’s rest and impaired sleep quality in patients with COPD
por: Hartman, J. E., et al.
Publicado: (2015)

Bioinformatics-based identification of potential microRNA biomarkers in frequent and non-frequent exacerbators of COPD
por: Liu, Xiao, et al.
Publicado: (2018)

Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators
por: Lu, Fang-Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_khi7vhpa47na5fdhrnrvn93m6i